Granulocyte - Colony-stimulating factor (Filgrastim) may overcome imatinib-induced neutropenia in patients with chronic-phase myelogenous leukemia [2]

Cancer

Volumn 103, Issue 1, 2005, Pages 210-

  Jørgensen, Heather G ^a   Copland, Mhairi ^a   Holyoake, Tessa L ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; CYTARABINE; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; IMATINIB; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHRONIC MYELOID LEUKEMIA; DRUG INDUCED DISEASE; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNE RESPONSE; LETTER; LEUKOCYTE COUNT; NEUTROPENIA; PRIORITY JOURNAL;

EID: 10844295907     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20742     Document Type: Letter

References (7)

1. Quintas-Cardama A, Kantarjian H, O'Brien S, et al. Granulocyte-colony- stimulating factor (Filgrastim) may overcome imatinib-induced neutropenia in patients with chronic-phase chronic myelogenous leukemia. Cancer. 2004;100:2592-2597.
2. Ogawa M. Differentation and proliferation of hematopoietic stem cells. Blood. 1993;81:2844-2853.
3. van Pelt K, de Haan G, Vellenga E, Daenen S. Rapid progression into S-phase of quiescent stem cells after chemotherapy [abstract]. Exp Hematol. 2003;31:195.
4. -) hematopoietic cells show altered expression of a subset of genes associated with early acting cytokine and differentiation responses of their adult counterparts. Blood. 2000;96:4160-4168.
5. Copland M, Jørgensen HG, Allan EK, et al. G-CSF with pulsed imatinib effectively targets chronic myeloid leukaemia stem cells in vitro [abstract]. Exp Hematol. 2004;32:90.
6. Graham S, Jørgensen H, Allan E, et al. Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. Blood. 2004;99:319-325.
7. Lowenburg B, van Putten W, Theobald M, et al. Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukaemia. N Engl J Med. 2003;349:743-752.